Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension

Kidney International

Volumn 57, Issue 4, 2000, Pages 1404-1407

  Williams, Gordon H ^a,b,c   Fisher, Naomi D L ^a,b,c   Hunt, Steve C ^a,b,c   Jeunemaitre, Xavier ^a,b,c   Hopkins, Paul N ^a,b,c   Hollenberg, Norman K ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c PSL Research University   (France)

Author keywords

Angiotensinogen gene; Blood pressure; Essential hypertension; Phenotype for hypertension; Sex hormones

Indexed keywords

4 AMINOHIPPURIC ACID; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSINOGEN; DNA; RENIN; SEX HORMONE;

ALDOSTERONE BLOOD LEVEL; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; ESTROGEN THERAPY; GENOTYPE; HUMAN; KIDNEY BLOOD FLOW; PHENOTYPE; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM INTAKE;

EID: 0034127068     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00982.x     Document Type: Conference Paper

References (16)

1. 1. WARD R: Familial aggregation in genetic epidemiology of blood pressure, in Hypertension: Pathophysiology, Diagnosis and Management (2nd ed), edited by LARAGH J, BRENNER B, New York, Raven Press Publishers, 1995, pp 67-86
2. 2. WILLIAMS GH, FISHER NDL: Genetic approach to diagnostic and therapeutic decisions in human hypertension. Curr Opin Nephrol Hypertens 6:199-204, 1997
3. 3. SHOBECK DM, WILLIAMS GH, MOORE TJ, DLUHY RG, PODOLSKY S, HOLLENBERG NK: Defect in the sodium modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 72:2115-2124, 1983
4. 4. WILLIAMS GH, DLUHY RG, LIFTON RP, MOORE TJ, GLEASON R, WILLIAMS RR, HUNT SC, HOPKINS PN, HOLLENBERG NK: Nonmodulation as an intermediate phenotype in essential hypertension. Hypertension 20:788-796, 1992
5. 5. HOPKINS PN, LIFTON RP, HOLLENBERG NK, JEUNEMAITRE X, HALLOUIN M-C, SKUPPIN J, WILLIAMS CS, DLUHY RG, LALOUEL J-M, WILLIAMS RR, WILLIAMS GH: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14:199-207, 1996
6. 6. FISHER NDL, FERRI C, BELLINI C, SANTUCCI A, GLEASON R, WILLIAMS GH, HOLLENBERG NK, SEELY EW: Age, gender, and nonmodulation: A sexual dimorphism in essential hypertension. Hypertension 29:980-985, 1997
7. 7. JEUNEMAITRE X, SOUBRIE TF, KOTELEVTSEV Y, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL J-M: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
8. 8. EMMANUEL R, CAIN JP, WILLIAMS GH: Double antibody radioimmunoassay of renin activity in angiolensin II in human peripheral plasma. J Lab Clin Med 81:632-640, 1973
9. 9. UNDERWOOD RH, WILLIAMS GH: The simultaneous measurement of aldosterone, cortisol and corticosterone in human peripheral plasma hy displacement analysis. J Lab Clin Med 79:848-862, 1972
10. 10. REDGRAVE J, RABINOWE S, HOLLENBERG NK, WILLIAMS GH: Correction of abnormal renal blood flow in response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest 75:1285-1290, 1985
11. 11. FERRI C, BELLINI C, DESIDERI G, VALENTI M, DEMATTIA G, SANTUCCI A, HOLLENBERG NK, WILLIAMS GH: Relationship between insulin resistance and the renin angiotensin system and hypertension: Linkage of metabolic abnormalities in cardiovascular risk. Diabetes 49:1623-1630, 1999
12. 12. DLUHY RG, SMITH K, TAYLOR T, HOLLENBERG NK, WILLIAMS GH: Prolonged converting enzyme inhibition in non-modulation hypertension. Hypertension 13:371-377, 1989
13. 13. UNEDA S, FUJISHIMA S, FUJIKI Y, TOCHIKUBO O, ODA H, ASAHINA S, KANEKO Y: Renal hemodynamics and the renin angiotensin system in adolescents genetically predisposed to essential hypertension. J Hypertens 2:437-439, 1984
14. 14. BARETTA-PICCOLI C, PUSTERLA C, STADLER P, WEIDMANN P: Blunted aldosterone responsiveness to angiotensin II in normotensive subjects wilh familial predisposition to essential hypertension. J Hypertens 6:57-61, 1988
15. 15. LIFTON RP, HOPKINS PN, WILLIAMS RR, HOLLENBERG NK, WILLIAMS GH, DLUHY RG: Evidence for heritability of non-modulating essential hypertension. Hypertension 13:884-889, 1989
16. 16. INOUE I, NAKAJIMA T, WILLIAMS, CS, QUACKENBUSH J, PURYEAR R, POWERS M, CHENG T, LUDWIG EH, SHARMA AM, HATA A, JEUNMAITRE X, LALOUEL JM: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797, 1997